Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
2021 · npj Precision Oncology · 270 citations
https://doi.org/10.1038/s41698-021-00168-1
J
Jasper Mullenders
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
4.4K
Citations
21
h-index
23
i10-index
Jasper Mullenders is an academic researcher from Hycult Biotech (Netherlands). The author has contributed to research in topics: Epigenetics and DNA Methylation & Bladder and Urothelial Cancer Treatments & CRISPR and Genetic Engineering. The author has an h-index of 21, co-authored 40 publications.
ORCID: 0000-0003-3737-6901Papers by this author
worksA Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
2009 · PLoS ONE · 141 citations
https://doi.org/10.1371/journal.pone.0004798
Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
2020 · STAR Protocols · 122 citations
https://doi.org/10.1016/j.xpro.2020.100019
Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model
2021 · Cell Reports · 51 citations
https://doi.org/10.1016/j.celrep.2021.109351
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
2023 · British Journal of Cancer · 21 citations
https://doi.org/10.1038/s41416-023-02494-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat